Tirzepatide is now approved for the treatment of obstructive sleep apnea, highlighting the drug class' potential in sleep medicine.

Bad news from the massive conglomerate, which owns Medicare Advantage market share leader UnitedHealthcare, spooked investors. “United runs a very tight ship,” said Brad Ellis, senior director ...

Zepbound is used for weight loss or obstructive sleep apnea (OSA) in certain adults. Zepbound is a liquid solution that comes in two forms: prefilled, single-dose injector pens single-dose vials ...

(Ivanhoe Newswire) --- Obstructive sleep apnea or OSA affects nearly a billion ... also known as Mounjaro or Zepbound. “It's called GLP one receptor,” said Atul Malhotra, MD from the UC ...

Children diagnosed with both severe epilepsy and CSA vs those diagnosed with severe epilepsy and OSA had a higher standard mortality ratio. Among children with severe epilepsy, sleep apnea is ...

Zepbound supports sustained weight loss for up to three years among adults with obesity and overweight who don’t have diabetes, according to a study presented this week at the European Congress on ...

The “secretive maze of marketing and enrollment incentives” surrounding Medicare Advantage costs taxpayers extra money and needs an overhaul, according to a new Senate report. The report by Sen.

A child’s bedroom should be a safe haven where they can get enough sleep to develop properly, but many bedrooms contain a hidden danger that is sure to make parents weary. A recent pair of studies has ...

Pa., said Mounjaro changed his life with 'significant' health benefits. He's calling for widespread access to GLP-1 ...

"We should not be losing sleep because somebody has not built any AI models," said Nandan Nilekani. He added that India has set up the Indian AI mission and has small models. "Now talks should be ...

LillyDirect also provides in-person and telehealth care for migraines, sleep apnea and memory difficulties ... for patients with prescriptions to Zepbound single-dose vials. Telehealth company ...

also known as Mounjaro or Zepbound. It's FDA approved to manage diabetes and obesity. Now, UC San Diego researchers have gotten it approved as the first effective drug therapy for sleep apnea.